Shield Therapeutics plc (STX.L)
Shield Therapeutics plc, a commercial stage specialty pharmaceutical company, focuses on development and commercialization of clinical-stage pharmaceuticals to treat unmet medical needs.
3.99-0.09%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago-11.3%
The outlook
Shield Therapeutics plc currently reads as neutral based on strong buy — 1.0 avg of 3 analysts, below its 50- & 200-day averages, 2% of the way from its 52-week low to high, avg target +317% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Analyst consensusStrong Buy — 1.0 avg of 3 analysts
Price trendBelow its 50- & 200-day averages
52-week range2% of the way from its 52-week low to high
Price targetAvg target +317% vs current price
Analyst price target
~12-month · 3 analysts16.67average target+317.4% vs now
Now 3.99
Low 12.00High 23.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$42.7M
52-wk high
12.50
52-wk low
3.80
50-day avg
6.12
200-day avg
8.33
Trailing P/E
—